Home7BG • FRA
add
Oncoinvent ASA
Previous close
€4.42
Day range
€4.42 - €4.44
Year range
€0.00010 - €4.67
Avg Volume
22.00
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (NOK) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 5.98M | 17,750.75% |
Operating expense | 31.99M | -25.04% |
Net income | -25.99M | 39.17% |
Net profit margin | -434.65 | 99.66% |
Earnings per share | — | — |
EBITDA | -23.88M | 40.82% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (NOK) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 75.38M | — |
Total assets | 104.34M | — |
Total liabilities | 34.88M | — |
Total equity | 69.46M | — |
Shares outstanding | 977.43K | — |
Price to book | 0.06 | — |
Return on assets | -62.32% | — |
Return on capital | -85.92% | — |
Cash Flow
Net change in cash
| (NOK) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -25.99M | 39.17% |
Cash from operations | -33.31M | 5.86% |
Cash from investing | — | — |
Cash from financing | 4.17M | -88.44% |
Net change in cash | -29.14M | -1,689.80% |
Free cash flow | -11.63M | — |
About
Founded
2007
Website
Employees
36
